( ARTG ) PALYNZIQ is indicated for the treatment of patients with phenylketonuria (PKU) aged 16 years and older who have inadequate blood phenylalanine control despite prior management with available treatment options.

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-

OTC

Palynziq Solution for Injection 10mg

INN: PEGVALIASE

Data updated: 2026-04-24

Available in:

🇨🇿🇬🇧🇵🇹🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

ATC Code

A16AB19

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.